Log in to search using one of your social media accounts:

 

Rufinamide (Rufinamide Tablets) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - June 15, 2016 Category: Drugs & Pharmacology Source Type: news

Glenmark gets final nod by USFDA to sell Rufinamide drug
Rufinamide is used to treat seizures caused by Lennox-Gastaut syndrome, it will be available as tablets in 200 mg and 400 mg strengths. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - May 19, 2016 Category: Pharmaceuticals Source Type: news

Glenmark gets tentative USFDA nod to sell Rufinamide
Glenmark Pharmaceuticals today said it has been granted tentative approval by the US health regulator to sell Rufinamide. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - May 21, 2015 Category: Pharmaceuticals Source Type: news

Japan's Eisai receives FDA expanded approval for antiepileptic drug Banzel
Japanese pharmaceutical company Eisai has received expanded approval from the US Food and Drug Administration (FDA) for its antiepileptic drug (AED), Banzel (rufinamide) to treat children and infants. (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - February 16, 2015 Category: Pharmaceuticals Source Type: news

Efficacy and Safety of Rufinamide in Pediatric EpilepsyEfficacy and Safety of Rufinamide in Pediatric Epilepsy
Rufinamide, a novel anticonvulsant approved for the treatment of seizures associated with Lennox-Gastaut syndrome, is proving to be a valuable treatment option in pediatric epilepsy. Therapeutic Advances in Neurological Disorders (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - July 15, 2013 Category: Consumer Health News Tags: Neurology & Neurosurgery Journal Article Source Type: news